Evening of 25th September 2018
PEPTINOV Conference & Cocktail
Meet the management of two innovative start-ups, in the process of raising funds, one specializing in the treatment of chronic inflammatory diseases, the other in cancer treatments:
PEPTINOV is a biotechnology company specializing in the research and development of active immunotherapy for the treatment of chronic inflammatory diseases and in particular osteoarthritis.
Peptinov team:
René AZOULAI, General Director
Hervé DO, CFO and VP Business Development
Jean-François ZAGURY, Founder and Scientific Director
Access to peptinov documents on the crowdfunding website Happy Capital